Percutaneous transhepatic cholangiography PTC - Biotech, Pharma and Life Science Channel

11:57 EDT 30th October 2014 | BioPortfolio

PubMed Articles [1014 Associated PubMed Articles listed on BioPortfolio]

Surgical Versus Percutaneous Revascularization in Patients with Multivessel Coronary Artery Disease.

New-generation stents have been continually developed in order to improve the safety and efficacy of percutaneous coronary intervention (PCI). Several randomized clinical trials have been conducted ov...

Dual Antiplatelet Therapy in the Anticoagulated Patient Undergoing Percutaneous Coronary Intervention Risks, Benefits, and Unanswered Questions.

A commonly encountered scenario is the patient with atrial fibrillation (AF) on oral anticoagulation (OAC) who either develops an acute coronary syndrome or has to undergo percutaneous coronary interv...

Use of Left Ventricular Support Devices During Acute Coronary Syndrome and Percutaneous Coronary Intervention.

In an effort to improve outcomes in percutaneous coronary intervention (PCI), percutaneous ventricular assist devices (PVADs) have been investigated in (1) high-risk PCI, (2) acute myocardial infarcti...

Stem Cell Therapy to Treat Heart Ischaemia: Implications for Diabetes Cardiovascular Complications.

Diabetes mellitus is a well-known risk factor for coronary artery disease (CAD), which can lead to acute myocardial infarction, chronic myocardial ischaemia and heart failure. Despite the advantages i...

Drug-eluting stents in unprotected left main coronary artery disease.

Though coronary bypass graft surgery (CABG) has traditionally been the cornerstone of therapy in patients with unprotected left main coronary artery (ULMCA) disease, recent evidence supports the use o...

The Evolution of Breast Imaging: Past to Present.

The practice of breast imaging has transitioned through a wide variety of technologic advances from the early days of direct-exposure film mammography to xeromammography to screen-film mammography to ...

Public reporting and coronary revascularization: risk and benefit.

Since the 1980s, the evolution of public reporting of provider-specific and institution-specific clinical outcomes has historically been rooted in the field of cardiology. Although public reporting is...

Long-term results of multiple arterial bypass conduits.

Ongoing efforts to compare percutaneous coronary intervention with coronary bypass surgery for multivessel coronary disease mandate that surgeons reevaluate best practices for coronary surgery in orde...

Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention.

Abstract We assessed the prognostic value of the platelet to lymphocyte ratio (PLR) in primary percutaneous coronary intervention (pPCI). Patients (n = 440) with acute myocardial infarction (AMI) ...

Impact of DRG Billing System on Health Budget Consumption in Percutaneous Treatment of Mitral Valve Regurgitation in Heart Failure.

Abstract Objective: Percutaneous correction of mitral regurgitation (MR) by MitraClip® (Abbot Vascular) trans-catheter procedure (MTP) may represent a treatment for an unmet need in heart failure (HF...

News Articles [199 Associated News Articles listed on BioPortfolio]

TMC jumps after court upholds Angiomax patent

The Medicines Co. (NASDAQ:MDCO) jumped $3.67 (17%) to $25.86 on Tuesday after the U.S. District Court for the Northern District of Illinois ruled that an ANDA filed by Mylan Inc. (NASDAQ:MYL) seeking ...

LEADING CANCER CENTERS TO PRESENT DATA FROM DELCATH'S CHEMOSAT/MELPHALAN HDS AT ESSO CONGRESS

New York, NY- October 28, 2014 - Delcath Systems, Inc. (NASDAQ: DCTH) announced today that data highlighting the potential of the Company's Hepatic CHEMOSAT® Delivery System/Melphalan HD...

PharmaBoardroom Sponsors 2014 Prix Galien Russia Ceremony Where Five Laureates Announced

LONDON, October 28, 2014 /PRNewswire/ -- The Prix Galien Russia Selection Committee bestowed prizes in the categories of Russian Innovation and R&D to Generium and the Engelhardt Institute, and t...

Cardiovascular Systems Enrolls First Seven Patients in Japan for Coast Study

International Coronary Trial Underway in United States and Japan Study to Assess Safety and Efficacy of New Coronary Micro Crown to Secure Regulatory App...

3D Systems Expands Simbionix™ Product Portfolio for Surgeons

ROCK HILL, S.C., Oct. 27, 2014 /PRNewswire/ -- 3D Systems (NYSE: DDD) announced today that it will exhibit new Simbionix products, an essential part of its growing 3D healthcare portfolio, at the...

LVEF for Risk Stratification in Prevention of SCD After MI

What ejection fraction threshold identifies patients with a high incidence of inducible VT post- primary percutaneous coronary intervention? Europace

NICE draft guidance recommends Bayer’s Xarelto post heart attack

Draft guidance from UK health watchdog NICE recommends Bayer's rivaroxaban (Xarelto) for preventing blood clots in people who have had a heart attack as a result of a blockage or narrowing in one of t...

Aortic Valve Stenosis Treatment in Thailand by Phyathai 2 International Hospital

Phyathai 2 International Hospital’s Heart Center uses the latest techniques and technology available to investigate any heart conditions and provide the best treatment for ...

Veran Medical raises $12mm through third round

Veran Medical Technologies Inc. (lung cancer detection technology) will use the $12mm it received through its third financing round for continued commercialization in the US (and upcoming internationa...

Veran Medical Completes $12 Million in New Financing

ST. LOUIS, Mo., Oct. 20, 2014 /PRNewswire/ -- Veran Medical Technologies, a market leader in thoracic navigation for early detection of lung cancer, announced today the completion of a $12M ...

Events [0 Results]

None

Companies [15 Associated Companies listed on BioPortfolio]

Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. (OTCQB: CVRS) is a global technology leader in robotic-assisted percutaneous coronary interventions (PCIs). The Company’s FDA-cleared CorPath...

Osprey Medical Inc.

Osprey Medical's core technologies originated from research conducted by Dr David Kaye at Melbourne’s Baker IDI Heart and Diabetes Institute. Osprey is focused on improving p...

Mitralign, Inc.

Mitralign is a cardiac device company founded by the Accelerated Technologies (ATI) medical device incubator. The company has developed and is currently testing an innovative, cat...

BioCardia, Inc.

BioCardia, Inc., headquartered in San Carlos, CA is a privately-held commercial medical technology company that has developed percutaneous delivery systems for biologics to treat ...

InSeal Medical Ltd.

InSeal Medical Ltd. (Caesarea, Israel http://www.InSealMedical.com/) develops and manufactures percutaneous vascular closure devices for sealing of puncture site following a treat...

SpineAlign Medical, Inc.

The SpineAlign device represents the first of many new innovations in the area of minimally invasive percutaneous vertebral body reconstruction and augmentation to be developed by...

Corindus Vascular Robotics

Corindus designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s disposable medical device ...

Ischemix

Ischemix is a privately-held drug discovery company with a portfolio of small molecule therapeutic compounds. The first of these compounds is targeted to reduce cell death and org...

NeuroDigm

NeuroDigm Co. is helping companies solve the puzzle of chronic pain with the Hot Spot ModelTM of Neuropathic Pain. This is THE Alternative, Nonsurgical Model to create neuropathic pain as found in ...

Colibri Heart Valve, LLC

Colibri Heart Valve, LLC is a privately held medical device company committed to the research and development of novel heart valve technologies, including the Company’s dry, ...

Clinical Trials [428 Associated Clinical Trials listed on BioPortfolio]

RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT)

The objective of this trial is to demonstrate the safety and effectiveness of the Cardiva VASCADE™ Vascular Closure System (VCS) in sealing femoral arterial access sites. Hypothesis: Th...

Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation

This is a prospective, non-randomized, study of the safety and efficacy of the Occlutech® LAA occluder indicated for percutaneous LAA closure in adult male or female patients with atrial...

Transradial and Transfemoral Coronary Angiography by EXPERienced operaTors

Transradial approach (TRA) reduces vascular complications and access related-bleeding compared to transfemoral approach (TFA). However, this technique has been related to higher radiation ...

Ranolazine in Ischemic Cardiomyopathy

Patients with ischemic cardiomyopathy may continue to experience persistent chest pain and shortness of breath despite conventional medical therapy and/or revascularization. The purpose o...

CYP2C19 Gene Alteration and Thienopyridine Resistance in Percutaneous Coronary Intervention Study

Dual antiplatelet therapy with aspirin and thienopyridines decreases the rate of stent thrombosis in patients undergoing percutaneous coronary intervention (PCI). However, despite intensif...

CoreValve® System Australia/New Zealand Clinical Study

To evaluate the performance, efficacy and safety of the percutaneous implantation of the CoreValve® prosthetic aortic valve in patients with severe symptomatic native aortic valve stenosi...

Treatment of Thoracolumbar Spine Fractures: Percutaneously Placed Pedicle Screws Versus Open Treatment

In patients presenting with Type A and Type B1, B2 thoracolumbar fractures, there is a lack of evidence demonstrating similar outcomes between patients treated with percutaneous pedicle sc...

Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris

Molsidomine used as an add-on treatment on standard care therapy should be superior to placebo used also as an add-on treatment on standard care therapy on improving the endothelial functi...

French Database of Left Atrial Appendage Closure

Patients with atrial fibrillation are exposed to a high risk of thrombus in the left atrium that can induce cerebral vascular events or systemic embolisms. This justifies the prescription ...

The Nordic-Baltic Bifurcation Study IV

How should coronary artery stenoses with significant side branch be stented? A strategy of stenting both main vessel and side branch compared to a strategy of stenting the main vessel and...

Medical and Biotech [MESH] Definitions

Diagnostic and therapeutic procedures that are invasive or surgical in nature, and require the expertise of a specially trained radiologist. In general, they are more invasive than diagnostic imaging but less invasive than major surgery. They often involve catheterization, fluoroscopy, or computed tomography. Some examples include percutaneous transhepatic cholangiography, percutaneous transthoracic biopsy, balloon angioplasty, and arterial embolization.

Percutaneous excision of a herniated or displaced intervertebral disk by posterolateral approach, always remaining outside the spinal canal. Percutaneous nucleotomy was first described by Hijikata in Japan in 1975. In 1985 Onik introduced automated percutaneous nucleotomy which consists in percutaneous aspiration of the nucleus pulposus. It is carried out under local anesthesia, thus reducing the surgical insult and requiring brief hospitalization, often performed on an outpatient basis. It appears to be a well-tolerated alternative to surgical diskectomy and chymopapain nucleolysis.

Excision, in part or whole, of an intervertebral disk. The most common indication is disk displacement or herniation. In addition to standard surgical removal, it can be performed by percutaneous diskectomy (DISKECTOMY, PERCUTANEOUS) or by laparoscopic diskectomy, the former being the more common.

Surgery of the smooth muscle sphincter of the hepatopancreatic ampulla to relieve blocked biliary or pancreatic ducts.

A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Percutaneous transhepatic cholangiography PTC market research data and corporate reports here

Channels Quicklinks